3D Signatures Inc.CANNOT EXHIBIT, OWES ASH & ASCO

MaRS Centre, South Tower
101 College St. Suite 200
TORONTO,  ON  M5G 1L7

Canada
http://www.3dsignatures.com
  • Booth: 5117

3DS (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) is a personalized medicine company with a proprietary software platform based on the three-dimensional analysis of chromosomal signatures. The technology is well developed and supported by 22 clinical studies on over 2,000 patients on 13 different cancers and Alzheimer’s disease. Depending on the desired application, this platform technology can measure the stage of disease, rate of progression of disease, drug efficacy, and drug toxicity. The technology is designed to predict the course of disease and to personalize treatment for the individual patient.


  •  
  •      
     

  •  
  •